# Expert Opinion on Pharmacotherapy

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/expert-opinion-on-pharmacotherapy/

## Facts

| Field | Value |
| --- | --- |
| Citations | 139,232 |
| h-index | 119 |
| Homepage | http://informahealthcare.com/journal/eop |
| Open Access | false |
| ISSN-L | 1465-6566 |
| ISSNs | 1465-6566,1744-7666 |
| OpenAlex ID | https://openalex.org/S52020611 |
| Publisher | Taylor & Francis |
| Works | 6,579 |

## Journal papers

Showing 12 of 18.

- [The epidemiology, economic burden, and pharmacological treatment of chronic low back pain in France, Germany, Italy, Spain and the UK: a literature-based review](https://scholariq.org/papers/the-epidemiology-economic-burden-and-pharmacological-treatment-of-chronic-low/)
- [Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections](https://scholariq.org/papers/nitazoxanide-a-broad-spectrum-thiazolide-anti-infective-agent-for-the-treatment/)
- [The pharmacological management of chronic lower back pain](https://scholariq.org/papers/the-pharmacological-management-of-chronic-lower-back-pain/)
- [<b>Current options for the treatment of<i>Helicobacter pylori</i></b>](https://scholariq.org/papers/b-current-options-for-the-treatment-of-i-helicobacter-pylori-i-b/)
- [Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan](https://scholariq.org/papers/efficacy-and-safety-of-memantine-in-patients-with-moderate-to-severe-alzheimer-s/)
- [Pharmacotherapeutic strategies for the treatment of attention-deficit hyperactivity (ADHD) disorder with comorbid substance-use disorder (SUD)](https://scholariq.org/papers/pharmacotherapeutic-strategies-for-the-treatment-of-attention-deficit/)
- [The use of stimulants and atomoxetine in adults with comorbid ADHD and bipolar disorder](https://scholariq.org/papers/the-use-of-stimulants-and-atomoxetine-in-adults-with-comorbid-adhd-and-bipolar/)
- [The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia](https://scholariq.org/papers/the-effects-of-rosuvastatin-alone-or-in-combination-with-fenofibrate-or-omega-3/)
- [Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD)](https://scholariq.org/papers/current-and-emerging-pharmacotherapy-for-the-treatment-of-adult-attention/)
- [An evaluation of voclosporin for the treatment of lupus nephritis](https://scholariq.org/papers/an-evaluation-of-voclosporin-for-the-treatment-of-lupus-nephritis/)
- [The pharmacological management of constipation in patients with Parkinson’s disease: a much-needed relief](https://scholariq.org/papers/the-pharmacological-management-of-constipation-in-patients-with-parkinson-s/)
- [Pharmacotherapy of insomnia](https://scholariq.org/papers/pharmacotherapy-of-insomnia/)

## Journal top topics

Showing 8 of 25.

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Bipolar Disorder and Treatment](https://scholariq.org/topics/bipolar-disorder-and-treatment/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
